PPARA and metabolic disease: Since PPAR-α and γ can modulate metabolic disorders associated with inflammation (Pirozzi et al., 2016) and the inflammatory process itself (D’Agostino et al., 2007; Bensinger and Tontonoz, 2008; Russo et al., 2016), we evaluated if PHAS treatment is able to influence PPAR expression.